Published on: 3/5/2025
Blurred vision from Ozempic can sometimes go away, but it's very important to talk to your doctor for the best advice.
Some people taking Ozempic, a medicine used for diabetes and weight loss, have reported that their vision gets blurry. Research has shown that these changes, like blurred vision or dark spots (called central scotomas), can be reversible. This means that your vision might go back to normal once your body adjusts or if you stop the medication. However, every person is different, and not everyone will have the same experience. If you notice blurry vision while taking Ozempic, you should not stop the medicine on your own. Instead, visit your doctor or eye care provider. Sometimes, a change in dose or a switch to another treatment may help. Regular eye check-ups and discussing any changes in your vision with your healthcare provider are very important to keep your eyes healthy.
(References)
Newman T. Drugs like Ozempic, Wegovy linked to eye condition causing vision loss. Medical News Today. July 5, 2024. Accessed January 30, 2025.
Bracha P, Johnson W, Chu S, Davison J. Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide. _Am J Ophthalmol Case Rep_. 2024 December;36:102121. doi:10.1016/j.ajoc.2024.102121.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Purpose and positioning of servicesUbie Doctor’s Note is a service for informational purposes, and the provision of information by physicians, medical professionals, etc. is not a medical practice. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.